Understanding how RNA nanomedicines work and their effects on cancer treatment
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines
This study is exploring how tiny RNA-based medicines can be better delivered to treat cancer by figuring out how they interact with the body, so we can create more effective treatments that specifically target cancer cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon State University NIH-funded |
| Lab location | 1 site (Corvallis, United States) |
| Project ID | NIH-11003702 on NIH RePORTER |
What this research studies
This research investigates how RNA-based nanomedicines can be effectively delivered to treat cancer. It focuses on understanding the interactions between lipid nanoparticles and biological systems to improve their accumulation in tumors. By using a diverse library of materials and advanced assays, the research aims to uncover the fundamental principles that govern the behavior of these nanoparticles in the body. The ultimate goal is to develop better RNA nanomedicines that can target cancer cells more efficiently.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors who may benefit from advanced RNA-based therapies.
Not a fit: Patients with non-cancerous conditions or those not eligible for RNA nanomedicine treatments may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments using RNA nanomedicines.
How similar studies have performed: Other research has shown promise in using RNA nanomedicines for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Corvallis, United States
- Oregon State University — Corvallis, United States (Active)
Researchers
- Principal investigator: Sun, Conroy Ghin Chee — Oregon State University
- Study coordinator: Sun, Conroy Ghin Chee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.